{"id":"https://openalex.org/W2805634574","doi":"https://doi.org/10.1016/j.ejmech.2018.06.004","title":"Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors","display_name":"Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors","publication_year":2018,"publication_date":"2018-06-04","ids":{"openalex":"https://openalex.org/W2805634574","doi":"https://doi.org/10.1016/j.ejmech.2018.06.004","mag":"2805634574","pmid":"https://pubmed.ncbi.nlm.nih.gov/29885574"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejmech.2018.06.004","doi":"https://doi.org/10.1016/j.ejmech.2018.06.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2018.06.004","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085868377","display_name":"M.K. Ibrahim","orcid":"https://orcid.org/0009-0006-8054-4287","observed_orcids":["https://orcid.org/0009-0006-8054-4287"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"M.K. Ibrahim","raw_affiliation_strings":["Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007786874","display_name":"Mohammed S. Taghour","orcid":"https://orcid.org/0000-0003-0630-709X","observed_orcids":["https://orcid.org/0000-0003-0630-709X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"M.S. Taghour","raw_affiliation_strings":["Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088150567","display_name":"Ahmed M. Metwaly","orcid":"https://orcid.org/0000-0001-8566-1980","observed_orcids":["https://orcid.org/0000-0001-8566-1980"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"A.M. Metwaly","raw_affiliation_strings":["Pharmacognosy Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt"],"raw_orcid":"https://orcid.org/0000-0001-8566-1980","affiliations":[{"raw_affiliation_string":"Pharmacognosy Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016921887","display_name":"Amany Belal","orcid":"https://orcid.org/0000-0003-1045-0163","observed_orcids":["https://orcid.org/0000-0003-1045-0163"]},"institutions":[{"id":"https://openalex.org/I113643904","display_name":"Beni-Suef University","ror":"https://ror.org/05pn4yv70","country_code":"EG","type":"education","lineage":["https://openalex.org/I113643904"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"A. Belal","raw_affiliation_strings":["Medicinal Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt"],"raw_orcid":"https://orcid.org/0000-0003-1045-0163","affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt","institution_ids":["https://openalex.org/I113643904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044030554","display_name":"Ahmed B. M. Mehany","orcid":"https://orcid.org/0000-0002-9913-5380","observed_orcids":["https://orcid.org/0000-0002-9913-5380"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"A.B.M. Mehany","raw_affiliation_strings":["Zoology Department, Faculty of Science, Al-Azhar University, Cairo, 11884, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zoology Department, Faculty of Science, Al-Azhar University, Cairo, 11884, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113843142","display_name":"Mostafa A. Elhendawy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.A. Elhendawy","raw_affiliation_strings":["National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035057631","display_name":"Mohamed M. Radwan","orcid":"https://orcid.org/0000-0002-7393-8601","observed_orcids":["https://orcid.org/0000-0002-7393-8601"]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.M. Radwan","raw_affiliation_strings":["National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034984951","display_name":"Abdelrahman Mohamed Yassin","orcid":"https://orcid.org/0000-0001-6780-1521","observed_orcids":["https://orcid.org/0000-0001-6780-1521"]},"institutions":[{"id":"https://openalex.org/I4210101365","display_name":"City of Scientific Research and Technological Applications","ror":"https://ror.org/00pft3n23","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210101365"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"A.M. Yassin","raw_affiliation_strings":["Biopharmaceutical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt","institution_ids":["https://openalex.org/I4210101365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062666165","display_name":"Nehal M. El\u2010Deeb","orcid":"https://orcid.org/0000-0002-8561-9456","observed_orcids":["https://orcid.org/0000-0002-8561-9456"]},"institutions":[{"id":"https://openalex.org/I4210101365","display_name":"City of Scientific Research and Technological Applications","ror":"https://ror.org/00pft3n23","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210101365"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"N.M. El-Deeb","raw_affiliation_strings":["Biopharmaceutical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt","institution_ids":["https://openalex.org/I4210101365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078773891","display_name":"E. S. E. Hafez","orcid":"https://orcid.org/0000-0003-4044-5103","observed_orcids":["https://orcid.org/0000-0003-4044-5103"]},"institutions":[{"id":"https://openalex.org/I4210101365","display_name":"City of Scientific Research and Technological Applications","ror":"https://ror.org/00pft3n23","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210101365"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"E.E. Hafez","raw_affiliation_strings":["Department of Plant Protection and Biomolecular Diagnosis, ALCRI City of Scientific Research and Technological Applications, Alexandria, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Plant Protection and Biomolecular Diagnosis, ALCRI City of Scientific Research and Technological Applications, Alexandria, Egypt","institution_ids":["https://openalex.org/I4210101365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046094471","display_name":"Mahmoud A. ElSohly","orcid":"https://orcid.org/0000-0002-0019-2001","observed_orcids":["https://orcid.org/0000-0002-0019-2001"]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M.A. ElSohly","raw_affiliation_strings":["National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA. Electronic address: mmelsohly@olemiss.edu","National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA. Electronic address: mmelsohly@olemiss.edu","institution_ids":["https://openalex.org/I368840534"]},{"raw_affiliation_string":"National Center for Natural Products Research, University of Mississippi, University, MS, 38677, USA","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020589815","display_name":"Ibrahim H. Eissa","orcid":"https://orcid.org/0000-0002-6955-2263","observed_orcids":["https://orcid.org/0000-0002-6955-2263"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"I.H. Eissa","raw_affiliation_strings":["Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt. Electronic address: Ibrahimeissa@azhar.edu.eg","Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-6955-2263","affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt. Electronic address: Ibrahimeissa@azhar.edu.eg","institution_ids":["https://openalex.org/I184834183"]},{"raw_affiliation_string":"Medicinal Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt","institution_ids":["https://openalex.org/I184834183"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020589815","https://openalex.org/A5046094471"],"corresponding_institution_ids":["https://openalex.org/I184834183","https://openalex.org/I368840534"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":5.5983,"has_fulltext":false,"cited_by_count":130,"citation_normalized_percentile":{"value":0.97385708,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"155","issue":null,"first_page":"117","last_page":"134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.3693999946117401,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.03440000116825104,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinoxaline-derivatives","display_name":"quinoxaline derivatives","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dna-intercalators","display_name":"DNA intercalators","score":0.8809999823570251},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7580000162124634},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dna-binding-affinity","display_name":"DNA binding affinity","score":0.7540000081062317},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.9549999833106995},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/caco-2-cells","display_name":"Caco-2 cells","score":0.9330000281333923},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6100000143051147},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8655297756195068},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7922871112823486},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.7885233759880066},{"id":"https://openalex.org/C2780362310","wikidata":"https://www.wikidata.org/wiki/Q419930","display_name":"Quinoxaline","level":2,"score":0.7379002571105957},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5992975831031799},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5710310935974121},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5357005000114441},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5078175663948059},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.49377259612083435},{"id":"https://openalex.org/C137824038","wikidata":"https://www.wikidata.org/wiki/Q175562","display_name":"Intercalation (chemistry)","level":2,"score":0.43201541900634766},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4165400564670563},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41110140085220337},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3382551372051239},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08745169639587402},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053837","descriptor_name":"DNA Cleavage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejmech.2018.06.004","doi":"https://doi.org/10.1016/j.ejmech.2018.06.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2018.06.004","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:29885574","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29885574","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8199999928474426,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W1432871984","https://openalex.org/W1576422728","https://openalex.org/W1646042990","https://openalex.org/W1883052546","https://openalex.org/W1965326858","https://openalex.org/W1965948555","https://openalex.org/W1971318845","https://openalex.org/W1974546096","https://openalex.org/W1982607298","https://openalex.org/W1982861164","https://openalex.org/W1983790923","https://openalex.org/W1983940544","https://openalex.org/W1989363513","https://openalex.org/W1993716635","https://openalex.org/W2007184881","https://openalex.org/W2008979681","https://openalex.org/W2016788237","https://openalex.org/W2017073563","https://openalex.org/W2019759220","https://openalex.org/W2027275489","https://openalex.org/W2035105910","https://openalex.org/W2043639805","https://openalex.org/W2048465998","https://openalex.org/W2059049151","https://openalex.org/W2062299665","https://openalex.org/W2068577449","https://openalex.org/W2077804275","https://openalex.org/W2080215881","https://openalex.org/W2086037731","https://openalex.org/W2088483249","https://openalex.org/W2088686339","https://openalex.org/W2102345056","https://openalex.org/W2106926141","https://openalex.org/W2127264662","https://openalex.org/W2134486128","https://openalex.org/W2152990948","https://openalex.org/W2156373035","https://openalex.org/W2171216363","https://openalex.org/W2314912618","https://openalex.org/W2326231942","https://openalex.org/W2344545249","https://openalex.org/W2395523735","https://openalex.org/W2418046358","https://openalex.org/W2418540139","https://openalex.org/W2473328171","https://openalex.org/W2494441533","https://openalex.org/W2523157690","https://openalex.org/W2538465384","https://openalex.org/W2590070203","https://openalex.org/W2733930358","https://openalex.org/W2735225452","https://openalex.org/W2740059367","https://openalex.org/W2749897366","https://openalex.org/W2771510573","https://openalex.org/W2782301747","https://openalex.org/W2796152634","https://openalex.org/W2950058521","https://openalex.org/W2951084559","https://openalex.org/W4254485199","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2970220863","https://openalex.org/W3082495518","https://openalex.org/W2735225452","https://openalex.org/W3094082197","https://openalex.org/W3107817176","https://openalex.org/W4281692041","https://openalex.org/W3127561829","https://openalex.org/W4318580655","https://openalex.org/W7214383977","https://openalex.org/W3081465438"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-13T00:00:00"}